scholarly article | Q13442814 |
P50 | author | John S. Duncan | Q6256238 |
Ley Sander | Q6537960 | ||
P2093 | author name string | O'Donoghue MF | |
P2860 | cites work | Statistical methods for assessing agreement between two methods of clinical measurement | Q26778461 |
P433 | issue | 6 | |
P921 | main subject | seizure | Q6279182 |
P304 | page(s) | 563-571 | |
P577 | publication date | 1996-06-01 | |
P1433 | published in | Epilepsia | Q5382969 |
P1476 | title | The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale. | |
P478 | volume | 37 |
Q34992393 | (Cost)-effectiveness of a multi-component intervention for adults with epilepsy: study protocol of a Dutch randomized controlled trial (ZMILE study) |
Q33787985 | A Retrospective Cohort Study to Assess Patient and Physician Reported Outcome Measures After Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Stroke |
Q40827463 | A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy |
Q77530518 | Adjunctive therapy in epilepsy with new antiepileptic drugs: is it of any value? |
Q51083233 | Affective aggression in patients with temporal lobe epilepsy: a quantitative MRI study of the amygdala. |
Q93029514 | An evaluation of the psychosocial impact of epilepsy on marriage in the United Kingdom |
Q41506430 | Assessing changes over time in temporal lobectomy: outcome by scoring seizure frequency |
Q46938038 | Assessing severity of epilepsy in children: preliminary evidence of validity and reliability of a single-item scale. |
Q48225021 | Asymmetry of cerebral blood flow measured with three-dimensional pseudocontinuous arterial spin-labeling mr imaging in temporal lobe epilepsy with and without mesial temporal sclerosis |
Q37340458 | Automatic Vagus Nerve Stimulation Triggered by Ictal Tachycardia: Clinical Outcomes and Device Performance--The U.S. E-37 Trial |
Q44565488 | Cerebellar volume is linked to cognitive function in temporal lobe epilepsy: a quantitative MRI study |
Q33784884 | Cerebellum abnormalities in idiopathic generalized epilepsy with generalized tonic-clonic seizures revealed by diffusion tensor imaging |
Q55396526 | Changes in Dynamics Within and Between Resting-State Subnetworks in Juvenile Myoclonic Epilepsy Occur at Multiple Frequency Bands. |
Q35617456 | Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy |
Q47442842 | Clinical characteristics of patients with epilepsy in a specialist neuropsychiatry service |
Q45326701 | Clinical risk factors for depressive symptoms in patients with epilepsy |
Q35453495 | Comparative double blind clinical trial of phenytoin and sodium valproate as anticonvulsant prophylaxis after craniotomy: efficacy, tolerability, and cognitive effects |
Q40628130 | Determinants of disease severity in adults with epilepsy: Results from the Neurological Diseases and Depression Study |
Q44572281 | Determining minimally important change thresholds for the Seizure Severity Questionnaire (SSQ). |
Q46716550 | Developing the Pediatric Refractory Epilepsy Questionnaire: a pilot study |
Q77794013 | Development of a new seizure severity questionnaire: initial reliability and validity testing |
Q48366186 | Dissociative experiences and quality of life in patients with non-epileptic attack disorder |
Q41678104 | Dynamic Susceptibility Contrast Enhanced (DSC) MRI Perfusion and Plasma Cytokine Levels in Patients after Tonic-clonic Seizures |
Q37778625 | Effect of antiepileptic drugs on the postictal state. A critical overview |
Q49962031 | Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): A randomized controlled trial. |
Q89620651 | Evaluating the Effectiveness and Cost-Effectiveness of Seizure Dogs in Persons With Medically Refractory Epilepsy in the Netherlands: Study Protocol for a Stepped Wedge Randomized Controlled Trial (EPISODE) |
Q41642476 | Evaluation of drug treatment outcome in epilepsy: a clinical perspective |
Q35917748 | Fish Oil Intake and Seizure Control in Children with Medically Resistant Epilepsy |
Q33909481 | Help seeking and suicidality among people with epilepsy in a rural low income country setting: cross-sectional survey |
Q43514403 | Increased ratio of glutamate/glutamine to creatine in the right hippocampus contributes to depressive symptoms in patients with epilepsy |
Q48099918 | Is antiepileptic drug withdrawal status related to quality of life in seizure-free adult patients with epilepsy? |
Q43420360 | Marital adjustment for patients with epilepsy in China |
Q33929669 | Measuring quality of life in epilepsy surgery patients. |
Q35216352 | Measuring the efficacy of antiepileptic drugs |
Q47876046 | Microstructural Alterations in Asymptomatic and Symptomatic Patients with Spinocerebellar Ataxia Type 3: A Tract-Based Spatial Statistics Study |
Q34312710 | Monotherapy trials: endpoints |
Q42691383 | Parents' caregiving approaches: facing a new treatment alternative in severe intractable childhood epilepsy |
Q51891737 | Prevalence, patterns, service needs, and assessment of neuropsychiatric disorders among people with epilepsy in residential care: validation of the Neuropsychiatric Inventory as a caregiver-rated measure of neuropsychiatric functioning in epilepsy. |
Q38144479 | Psychiatric adverse effects of zonisamide in patients with epilepsy and mental disorder comorbidities |
Q91949099 | Quality of Life and Its Determinants in Adult Drug Refractory Epilepsy Patients Who Were Not Candidates for Epilepsy Surgery: A Correlational Study |
Q53577848 | Quality of life research in adults with epilepsy in Japan. |
Q34156372 | Quantitative assessment of seizure severity for clinical trials: a review of approaches to seizure components |
Q33801753 | Research into the (Cost-) effectiveness of the ketogenic diet among children and adolescents with intractable epilepsy: design of a randomized controlled trial. |
Q30275879 | Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials. |
Q33929659 | Seizure control as an indicator of therapeutic usefulness |
Q47446258 | Seizure outcomes in patients with anti-NMDAR encephalitis: A follow-up study |
Q42630077 | Sensitivity testing of the Seizure Severity Questionnaire (SSQ). |
Q89236217 | Sexual dysfunction and associated factors in Chinese Han women with epilepsy |
Q92602905 | Social impairment and stigma in genetic generalized epilepsies |
Q34214261 | Standards for epidemiologic studies and surveillance of epilepsy |
Q50571737 | The MCT-ketogenic diet as a treatment option in refractory childhood epilepsy: A prospective study with 2-year follow-up. |
Q48058067 | The Personal Impact of Epilepsy Scale (PIES). |
Q53186000 | The effect of seizure severity on quality of life in epilepsy. |
Q38104378 | The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs |
Q48477097 | The ketogenic diet as a treatment option in adults with chronic refractory epilepsy: efficacy and tolerability in clinical practice |
Q30674774 | The promise of new antiepileptic drugs |
Q38784526 | Understanding the Patient Perspective of Seizure Severity in Epilepsy: Development of a Conceptual Model |
Q33864984 | VEP indices of cortical lateral interactions in epilepsy treatment |
Q48390407 | VNS in patients with previous unsuccessful resective epilepsy surgery: antiepileptic and psychotropic effects |
Q48056576 | What is in a number? The Personal Impact of Epilepsy Scale (PIES). |
Q81817716 | n-3 fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, exploratory study |
Search more.